Mythos AI found a critical Rejetto HFS flaw enabling admin-session forgery and arbitrary code execution via predictable Math.random() keys.

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today announced an extension of its data license agreement with Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX). Additionally, the two companies ...

Factorial Energy has signed a joint development agreement with Japan’s Mitsui Kinzoku for solid electrolytes, the latest in a run of partnerships its chief executive says are necessary because no ...

Solid-state battery specialist Factorial Energy is teaming up with Mitsui Kinzoku, one of the few companies producing sulfide-based solid electrolytes, to scale up the promising new technology.

WSJ Buy Side is The Wall Street Journal’s research and commerce team. Our commerce content is distinct from our newsroom coverage. We earn a commission from some links in our articles. Learn more.

Fermat’s last theorem, one of the most celebrated mathematical results of the past half-century, has been turned into computer-verified code for the first time, using an advanced prototype of the ...

For years now Tim Holme has watched the same drama repeat itself roughly once a week. A headline arrives: some laboratory somewhere has cracked the problem, invented the battery of the future, solved ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

BOSTON, Aug. 11, 2026 (GLOBE NEWSWIRE)-- Factorial Energy Inc. ("Factorial") (Nasdaq: FAC), a global leader in solid-state battery technology, today announced financial and business results for the ...

Illustration of Factorial’s FEST solid-state battery integrated onto the STLA Large platform. Credit: Stellantis N.V./BusinessWire. US-based Factorial Energy Inc., a tech firm specialising in ...

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...